As part of Platform Specialty Products, we have built a global organization that is ideally positioned to expand on our leadership in specialty segments. We have integrated three legacy companies with a highly complementary product portfolio and geographic footprint, and with strong partnerships with suppliers, distributors and end-users.
First and foremost, we are highly committed to innovation. Every year we dedicate a portion of our sales revenue to investments in new product development. This investment enables us to constantly renew our portfolio of differentiated solutions. Our R&D efforts focus on the development of new formulations, new active ingredient mixtures, and innovative delivery systems. Our library of active substances and core technologies continues to grow thanks to strategic partnerships with established chemistry-discovery companies and start-ups. These companies partner with Arysta LifeScience to enhance their market access in these specialty segments.
Investors choose Arysta LifeScience because of our ability to excel in fast-growing segments, achieve high margins with specialties, and maximize cash flows thanks to our unique “asset-lite” approach. With a lean network of flexible formulation facilities and the outsourcing of active ingredient production to cost-efficient quality suppliers, we have reduced the cost associated with fixed capital while keeping the agility to react quickly to changing market conditions.
Most importantly, farmers and distribution companies choose Arysta LifeScience because we will work closely with them to develop and promote the right solutions to fit local farming requirements in large and small crops. In short, we deliver results.